IRIX vs LLY · rev $12.6M vs P/E 39, rev $22.97B
IRIDEX Corporation (IRIX) versus Eli Lilly and Company (LLY) — a side-by-side from cached financials, not a winner call.
IRIDEX Corporation (IRIX) is a medical devices company listed on US.
Eli Lilly and Company (LLY) is a drug manufacturers - general company listed on NYSE. It is led by David Ricks.
Latest reported IRIX revenue for 2026-07-04 was $12.6M. Net income was -$1.3M. Revenue was up 6.5% from 2026-04-04 to 2026-07-04. IRIX currently screens at market cap $19.0M.
Latest reported LLY revenue for 2026-06-30 was $22.97B. Net income was $7.09B. Revenue was up 16.0% from 2026-03-31 to 2026-06-30. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
IRIX currently screens at market cap $19.0M. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
Not investment advice. Open the IRIX and LLY stock pages for the full models.
Not investment advice.